These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 17584562

  • 1. Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial.
    Dobre D, van Veldhuisen DJ, Mordenti G, Vintila M, Haaijer-Ruskamp FM, Coats AJ, Poole-Wilson PA, Flather MD, SENIORS Investigators.
    Am Heart J; 2007 Jul; 154(1):109-15. PubMed ID: 17584562
    [Abstract] [Full Text] [Related]

  • 2. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
    van Veldhuisen DJ, Cohen-Solal A, Böhm M, Anker SD, Babalis D, Roughton M, Coats AJ, Poole-Wilson PA, Flather MD, SENIORS Investigators.
    J Am Coll Cardiol; 2009 Jun 09; 53(23):2150-8. PubMed ID: 19497441
    [Abstract] [Full Text] [Related]

  • 3. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
    Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Soler-Soler J, Tavazzi L, Spinarova L, Toman J, Böhm M, Anker SD, Thompson SG, Poole-Wilson PA, SENIORS Investigators.
    Eur Heart J; 2005 Feb 09; 26(3):215-25. PubMed ID: 15642700
    [Abstract] [Full Text] [Related]

  • 4. Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS]).
    de Boer RA, Doehner W, van der Horst IC, Anker SD, Babalis D, Roughton M, Coats AJ, Flather MD, van Veldhuisen DJ, SENIORS Investigators.
    Am J Cardiol; 2010 Jul 01; 106(1):78-86.e1. PubMed ID: 20609652
    [Abstract] [Full Text] [Related]

  • 5. Influence of systolic blood pressure on clinical outcomes in elderly heart failure patients treated with nebivolol: data from the SENIORS trial.
    Montero-Perez-Barquero M, Flather M, Roughton M, Coats A, Böhm M, Van Veldhuisen DJ, Babalis D, Solal AC, Manzano L.
    Eur J Heart Fail; 2014 Sep 01; 16(9):1009-15. PubMed ID: 25044535
    [Abstract] [Full Text] [Related]

  • 6. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].
    Wolf SC, Buck-Müller N, Görner S, Risler T, Brehm BR.
    Med Klin (Munich); 2003 Jan 15; 98(1):1-6. PubMed ID: 12540987
    [Abstract] [Full Text] [Related]

  • 7. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW.
    Clin Ther; 2009 Mar 15; 31(3):447-62. PubMed ID: 19393838
    [Abstract] [Full Text] [Related]

  • 8. Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS.
    Mulder BA, van Veldhuisen DJ, Crijns HJ, Böhm M, Cohen-Solal A, Babalis D, Roughton M, Flather MD, Coats AJ, Van Gelder IC.
    Eur J Heart Fail; 2012 Oct 15; 14(10):1171-8. PubMed ID: 22764183
    [Abstract] [Full Text] [Related]

  • 9. Nebivolol for heart failure in the elderly.
    Tavazzi L.
    Expert Rev Cardiovasc Ther; 2007 May 15; 5(3):423-33. PubMed ID: 17489667
    [Abstract] [Full Text] [Related]

  • 10. Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study.
    von Haehling S, van Veldhuisen DJ, Roughton M, Babalis D, de Boer RA, Coats AJ, Manzano L, Flather M, Anker SD.
    Eur J Heart Fail; 2011 Jun 15; 13(6):656-63. PubMed ID: 21613429
    [Abstract] [Full Text] [Related]

  • 11. Failure of benefit and early hazard of bucindolol for Class IV heart failure.
    Anderson JL, Krause-Steinrauf H, Goldman S, Clemson BS, Domanski MJ, Hager WD, Murray DR, Mann DL, Massie BM, McNamara DM, Oren R, Rogers WJ, Beta-Blocker Evaluation of Survival Trial (BEST) Investigators.
    J Card Fail; 2003 Aug 15; 9(4):266-77. PubMed ID: 13680547
    [Abstract] [Full Text] [Related]

  • 12. Beta-blocker therapy in heart failure in the elderly.
    Fu M.
    Int J Cardiol; 2008 Apr 10; 125(2):149-53. PubMed ID: 18023898
    [Abstract] [Full Text] [Related]

  • 13. β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure.
    Ambrosio G, Flather MD, Böhm M, Cohen-Solal A, Murrone A, Mascagni F, Spinucci G, Conti MG, van Veldhuisen DJ, Tavazzi L, Coats AJ.
    Heart; 2011 Feb 10; 97(3):209-14. PubMed ID: 21138861
    [Abstract] [Full Text] [Related]

  • 14. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).
    Gullestad L, Wikstrand J, Deedwania P, Hjalmarson A, Egstrup K, Elkayam U, Gottlieb S, Rashkow A, Wedel H, Bermann G, Kjekshus J, MERIT-HF Study Group.
    J Am Coll Cardiol; 2005 Jan 18; 45(2):252-9. PubMed ID: 15653024
    [Abstract] [Full Text] [Related]

  • 15. Statin use and survival outcomes in elderly patients with heart failure.
    Ray JG, Gong Y, Sykora K, Tu JV.
    Arch Intern Med; 2005 Jan 10; 165(1):62-7. PubMed ID: 15642876
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.
    Deedwania PC, Giles TD, Klibaner M, Ghali JK, Herlitz J, Hildebrandt P, Kjekshus J, Spinar J, Vitovec J, Stanbrook H, Wikstrand J, MERIT-HF Study Group.
    Am Heart J; 2005 Jan 10; 149(1):159-67. PubMed ID: 15660048
    [Abstract] [Full Text] [Related]

  • 20. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.
    Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.